Phosphatidylinositol 3,5-bisphosphate increases intracellular free Ca2+ in arterial smooth muscle cells and elicits vasocontraction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 6, 2011, Pages

  Silswa, Neerupma ^a   Parelkar, Nikhil K ^a   Wacker, Michael J ^a   Brotto, Marco ^a   Andresen, Jon ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Aortic smooth muscle cells; Calcium; Ryanodine receptors; Sarcoplasmic reticulum

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CAFFEINE; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATASE; INOSITOL 1,4,5 TRISPHOSPHATASE RECEPTOR; PHOSPHATIDYLINOSITOL 3,5 BISPHOSPHATE; RYANODINE; RYANODINE RECEPTOR; THAPSIGARGIN; UNCLASSIFIED DRUG; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY CONSTRICTION; ARTERY MUSCLE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL ISOLATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE FIBER; VASCULAR RING;

ANIMALS; AORTA; CALCIUM; CALCIUM CHANNELS; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; PHOSPHATIDYLINOSITOL PHOSPHATES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; VASOCONSTRICTION;

EID: 79958041018     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01011.2010     Document Type: Article

References (78)

1. Aickin CC. Chloride Transport Across the Sarcolemma of Verterbrate Smooth and Skeletal Muscle. New York: Plenum, 1990.
2. Albert AP, Saleh SN, Large WA. Inhibition of native TRPC6 channel activity by phosphatidylinositol 4,5-bisphosphate in mesenteric artery myocytes. J Physiol 586: 3087-3095, 2008.
3. Ambudkar IS. TRPC1: a core component of store-operated calcium channels. Biochem Soc Trans 35: 96-100, 2007.
4. Ambudkar IS, Ong HL, Liu X, Bandyopadhyay BC, Cheng KT. TRPC1: the link between functionally distinct store-operated calcium channels. Cell Calcium 42: 213-223, 2007.
5. 2+ entry. Am J Physiol Cell Physiol 288: C872-C880, 2005.
6. Berwick DC, Dell GC, Welsh GI, Heesom KJ, Hers I, Fletcher LM, Cooke FT, Tavare JM. Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles. J Cell Sci 117: 5985-5993, 2004.
7. Bolino A, Bolis A, Previtali SC, Dina G, Bussini S, Dati G, Amadio S, Del Carro U, Mruk DD, Feltri ML, Cheng CY, Quattrini A, Wrabetz L. Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J Cell Biol 167: 711-721, 2004.
8. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou K, Hausmanowa-Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25: 17-19, 2000.
9. Bonangelino CJ, Nau JJ, Duex JE, Brinkman M, Wurmser AE, Gary JD, Emr SD, Weisman LS. Osmotic stress-induced increase of phospha- tidylinositol 3,5-bisphosphate requires Vac14p, an activator of the lipid kinase Fab1p. J Cell Biol 156: 1015-1028, 2002.
10. Chow CY, Landers JE, Bergren SK, Sapp PC, Grant AE, Jones JM, Everett L, Lenk GM, McKenna-Yasek DM, Weisman LS, Figlewicz D, Brown RH, Meisler MH. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 84: 85-88, 2009.
11. Chow CY, Zhang Y, Dowling JJ, Jin N, Adamska M, Shiga K, Szigeti K, Shy ME, Li J, Zhang X, Lupski JR, Weisman LS, Meisler MH. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448: 68-72, 2007.
12. De Camilli P, Emr SD, McPherson PS, Novick P. Phosphoinositides as regulators in membrane traffic. Science 271: 1533-1539, 1996.
13. 2+ pumps. Cell Calcium 26: 9-13, 1999.
14. DeHaven WI, Jones BF, Petranka JG, Smyth JT, Tomita T, Bird GS, Putney JW Jr. TRPC channels function independently of STIM1 and Orai1. J Physiol 587: 2275-2298, 2009.
15. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 443: 651-657, 2006.
16. + currents. Br J Pharmacol 127: 1819-1831, 1999.
17. Doughty JM, Langton PD. Measurement of chloride flux associated with the myogenic response in rat cerebral arteries. J Physiol 534: 753-761, 2001.
18. Doughty JM, Miller AL, Langton PD. Non-specificity of chloride channel blockers in rat cerebral arteries: block of the L-type calcium channel. J Physiol 507: 433-439, 1998.
19. Dove SK, Cooke FT, Douglas MR, Sayers LG, Parker PJ, Michell RH. Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis. Nature 390: 187-192, 1997.
20. 2 synthesis and turnover. J Cell Biol 172: 693-704, 2006.
21. 2+ release in preglomerular arterioles. Am J Physiol Renal Physiol 292: F1568-F1572, 2007.
22. Hassock SR, Zhu MX, Trost C, Flockerzi V, Authi KS. Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the store-independent calcium entry channel. Blood 100: 2801-2811, 2002.
23. 2+ release channel of vascular smooth muscle sarcoplasmic reticulum. Pflügers Arch 418: 353-359, 1991.
24. Hotta S, Morimura K, Ohya S, Muraki K, Takeshima H, Imaizumi Y. Ryanodine receptor type 2 deficiency changes excitation-contraction coupling and membrane potential in urinary bladder smooth muscle. J Physiol 582: 489-506, 2007.
25. Jardin I, Lopez JJ, Salido GM, Rosado JA. Functional relevance of the de novo coupling between hTRPC1 and type II IP3 receptor in storeoperated Ca2+ entry in human platelets. Cell Signal 20: 737-747, 2008.
26. Jones DR, Gonzalez-Garcia A, Diez E, Martinez AC, Carrera AC, Merida I. The identification of phosphatidylinositol 3,5-bisphosphate in T-lymphocytes and its regulation by interleukin-2. J Biol Chem 274: 18407-18413, 1999.
27. Kato K, Evans AM, Kozlowski RZ. Relaxation of endothelin-1-induced pulmonary arterial constriction by niflumic acid and NPPB: mechanism(s) independent of chloride channel block. J Pharmacol Exp Ther 288: 1242-1250, 1999.
28. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508: 199-209, 1998.
29. + channels in rabbit myogenic cerebral arteries. Am JPhysiol Heart Circ Physiol 269: H348-H355, 1995.
30. Kwan CY. Dysfunction of calcium handling by smooth muscle in hypertension. Can J Physiol Pharmacol 63: 366-374, 1985.
31. Laporte J, Bedez F, Bolino A, Mandel JL. Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Mol Genet 12: R285-R292, 2003.
32. Large WA, Saleh SN, Albert AP. Role of phosphoinositol 4,5-bisphosphate and diacylglycerol in regulating native TRPC channel proteins in vascular smooth muscle. Cell Calcium 45: 574-582, 2009.
33. 2+-activated Cl conductance in smooth muscle. Am J Physiol Cell Physiol 271: C435-C454, 1996.
34. 2+ channels by phosphatidylinositol 3,4,5-trisphosphate. Circ Res 95: 300-307, 2004.
35. Lesh RE, Nixon GF, Fleischer S, Airey JA, Somlyo AP, Somlyo AV. Localization of ryanodine receptors in smooth muscle. Circ Res 82: 175-185, 1998.
36. Li S, Tiab L, Jiao X, Munier FL, Zografos L, Frueh BE, Sergeev Y, Smith J, Rubin B, Meallet MA, Forster RK, Hejtmancik JF, Schorderet DF. Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy. Am J Hum Genet 77: 54-63, 2005.
37. Li S, Westwick J, Cox B, Poll CT. TRP channels as drug targets. Novartis Found Symp 258: 204-221 and 263-266, 2004.
38. Marks AR. Calcium channels expressed in vascular smooth muscle. Circulation 86: III61-III67, 1992.
39. McCrea HJ, De Camilli P. Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 24: 8-16, 2009.
40. 2+ release channel of sarcoplasmic reticulum. J Biol Chem 261: 6300-6306, 1986.
41. Michell RH, Heath VL, Lemmon MA, Dove SK. Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions. Trends Biochem Sci 31: 52-63, 2006.
42. Morel N, Vandenberg G, Ahrabi AK, Caron N, Desjardins F, Balligand JL, Horie S, Devuyst O. PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. Pflügers Arch 457: 845-856, 2009.
43. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol Cell Physiol 259: C3-C18, 1990.
44. 2+ entry in mouse pulmonary arterial smooth muscle cells. J Physiol 587: 2429-2442, 2009.
45. Nicot AS, Laporte J. Endosomal phosphoinositides and human diseases. Traffic 9: 1240-1249, 2008.
46. Ozaki S, DeWald DB, Shope JC, Chen J, Prestwich GD. Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers. Proc Natl Acad Sci USA 97: 11286-11291, 2000.
47. Parelkar NK, Silswal N, Jansen K, Vaughn J, Bryan RM Jr, Andresen J. 2,2,2-Trichloroethanol activates a nonclassical potassium channel incerebrovascular smooth muscle and dilates the middle cerebral artery. J Pharmacol Exp Ther 332: 803-810, 2010.
48. 2+ store depletion induces the formation of macromolecular complexes involving hTRPC1, hTRPC6, the type II IP3 receptor and SERCA3 in human platelets. Biochim Biophys Acta 1783: 1163-1176, 2008.
49. 2+ channels by lipids. Cell Calcium 45: 589-601, 2009.
50. Robinson FL, Dixon JE. Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol 16: 403-412, 2006.
51. Romero-Suarez S, Shen J, Brotto L, Hall T, Mo C, Valdivia HH, Andresen J, Wacker M, Nosek TM, Qu CK, Brotto M. Muscle-specific inositide phosphatase (MIP/MTMR14) is reduced with age and its loss accelerates skeletal muscle aging process by altering calcium homeostasis. Aging (Albany NY) 2: 504-513.
52. Sakai Y, Kwan CY. Calcium regulation and contractile dysfunction of smooth muscle. Biol Signals 2: 305-312, 1993.
53. Saleh SN, Albert AP, Large WA. Obligatory role for phosphatidylinositol 4,5-bisphosphate in activation of native TRPC1 store-operated channels in vascular myocytes. J Physiol 587: 531-540, 2009.
54. Saleh SN, Albert AP, Peppiatt-Wildman CM, Large WA. Diverse properties of store-operated TRPC channels activated by protein kinase C in vascular myocytes. J Physiol 586: 2463-2476, 2008.
55. 2+ channels. Cell Signal 21: 457-461, 2009.
56. 2+ entry. Biochim Biophys Acta 1793: 223-230, 2009.
57. Sampieri A, Diaz-Munoz M, Antaramian A, Vaca L. The foot structure from the type 1 ryanodine receptor is required for functional coupling to store-operated channels. J Biol Chem 280: 24804-24815, 2005.
58. Sbrissa D, Shisheva A. Acquisition of unprecedented phosphatidylinositol 3,5-bisphosphate rise in hyperosmotically stressed 3T3-L1 adipocytes, mediated by ArPIKfyve-PIKfyve pathway. J Biol Chem 280: 7883-7889, 2005.
59. 2+ homeostasis. Nat Cell Biol 11: 769-776, 2009.
60. 2+ entry. J Biol Chem 275: 36483-36486, 2000.
61. 2+ influx by interaction with a site in the C terminus of TrpC1. Mol Cell 9:739-750, 2002.
62. + channels. J Gen Physiol 130: 241-256, 2007.
63. 2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys 37: 175-195, 2008.
64. Suh BC, Hille B. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35: 507-520, 2002.
65. Suh BC, Hille B. Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate. Curr Opin Neurobiol 15: 370-378, 2005.
66. Suh BC, Hille B. Regulation of KCNQ channels by manipulation of phosphoinositides. J Physiol 582: 911-916, 2007.
67. 2 gate KCNQ ion channels. Science 314: 1454-1457, 2006.
68. Takahashi Y, Watanabe H, Murakami M, Ohba T, Radovanovic M, Ono K, Iijima T, Ito H. Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis 195: 287-296, 2007.
69. Tian W, Laffafian I, Dewitt S, Hallett MB. Exclusion of exogenous phosphatidylinositol-3,4,5-trisphosphate from neutrophil-polarizing pseudopodia: stabilization of the uropod and cell polarity. EMBO Rep 4: 982-988, 2003.
70. 2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet 15: 3098-3106, 2006.
71. 2) potentiates cardiac contractility via activation of the ryanodine receptor. J Biol Chem 285: 40312-40321, 2010.
72. Volpicelli-Daley L, De Camilli P. Phosphoinositides' link to neurodegeneration. Nat Med 13: 784-786, 2007.
73. 2+]i of rat isolated arterioles by ryanodine and cyclopiazonic acid. Circ Res 73: 465-472, 1993.
74. Welsh DG, Nelson MT, Eckman DM, Brayden JE. Swelling-activated cation channels mediate depolarization of rat cerebrovascular smooth muscle by hyposmolarity and intravascular pressure. J Physiol 527: 139-148, 2000.
75. Whiteford CC, Brearley CA, Ulug ET. Phosphatidylinositol 3,5-bisphosphate defines a novel PI 3-kinase pathway in resting mouse fibroblasts. Biochem J 323: 597-601, 1997.
76. 2+ stores in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 289: L338-L348, 2005.
77. Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS. Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci USA 104: 17518-17523, 2007.
78. 2+ channel/ ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol Rev 49: 1-51, 1997.